CNS leukemia response to treatment

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%

Patients who achieved and maintained CNS leukemia complete remission had the best 3-year survival at 60%, those with CNS relapse had 30% survival, and none of the patients with persistent CNS leukemia

Effect: improvement; 60% vs. 30% vs. 0%